Short Interest in Definitive Healthcare Corp. (NASDAQ:DH) Drops By 10.0%

Definitive Healthcare Corp. (NASDAQ:DH) was the target of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 2,890,000 shares, a decrease of 10.0% from the August 15th total of 3,210,000 shares. Currently, 5.9% of the shares of the company are sold short. Based on an average daily volume of 984,200 shares, the short-interest ratio is presently 2.9 days.

Definitive Healthcare Trading Down 3.8 %

DH traded down $0.18 during midday trading on Wednesday, reaching $4.56. 578,270 shares of the company’s stock traded hands, compared to its average volume of 827,679. The firm has a fifty day moving average of $4.65 and a two-hundred day moving average of $5.91. The stock has a market capitalization of $537.78 million, a price-to-earnings ratio of -2.61, a P/E/G ratio of 6.38 and a beta of 1.33. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40. Definitive Healthcare has a 52 week low of $3.19 and a 52 week high of $10.62.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings results on Monday, August 5th. The company reported $0.09 EPS for the quarter, meeting analysts’ consensus estimates of $0.09. The business had revenue of $63.70 million during the quarter, compared to analyst estimates of $63.19 million. Definitive Healthcare had a positive return on equity of 0.98% and a negative net margin of 156.65%. Definitive Healthcare’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.08 EPS. On average, equities analysts anticipate that Definitive Healthcare will post 0.07 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on DH. Robert W. Baird cut their price target on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a report on Tuesday, August 6th. JPMorgan Chase & Co. lowered Definitive Healthcare from a “neutral” rating to an “underweight” rating and cut their price target for the stock from $7.00 to $5.00 in a report on Wednesday, July 31st. BTIG Research started coverage on Definitive Healthcare in a research note on Tuesday. They set a “buy” rating and a $7.00 price objective for the company. Finally, Morgan Stanley dropped their price objective on Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating for the company in a research note on Tuesday, August 6th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Definitive Healthcare presently has an average rating of “Hold” and a consensus target price of $5.81.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in DH. Norden Group LLC purchased a new stake in shares of Definitive Healthcare in the 1st quarter worth approximately $83,000. Sanctuary Advisors LLC purchased a new stake in shares of Definitive Healthcare in the 2nd quarter worth approximately $85,000. Canada Pension Plan Investment Board purchased a new stake in shares of Definitive Healthcare in the 2nd quarter worth approximately $109,000. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Definitive Healthcare by 31.4% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock worth $116,000 after buying an additional 5,083 shares during the last quarter. Finally, Susquehanna Fundamental Investments LLC purchased a new stake in Definitive Healthcare during the 1st quarter valued at $120,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.